Sevelamer

Category: Hyperphosphatemia



Sevelamer Overview

Sevelamer (rINN) (/svlmr/ or /svlmr/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Contents 1 Chemistry and pharmacology 2 Medical uses 3 Contraindications 4 ...

Read more Sevelamer Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sevelamer

Recent Sevelamer Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sevelamer
  • Capsule: 400mg, 403mg
  • For Suspension: 2.4gm/packet, 800mg/packet
  • Tablet: 400mg, 800mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sevelamer: (3 results)

Sorted by National Drug Code
  • 0955-1048 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Winthrop U.S.
  • 68462-446 Sevelamer Hydrochloride 400 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
  • 68462-447 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA

Other drugs which contain Sevelamer or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA